EconPapers    
Economics at your fingertips  
 

A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes

Hyejin Lim, Yu-Mi Lim, Kook Hwan Kim, Young Eui Jeon, Kihyoun Park, Jinyoung Kim, Hui-Yun Hwang, Dong Jin Lee, Haushabhau Pagire, Ho Jeong Kwon, Jin Hee Ahn and Myung-Shik Lee ()
Additional contact information
Hyejin Lim: Severance Biomedical Science Institute
Yu-Mi Lim: Severance Biomedical Science Institute
Kook Hwan Kim: Severance Biomedical Science Institute
Young Eui Jeon: Yonsei University College of Dentistry
Kihyoun Park: SAIHST, Sungkyunkwan University
Jinyoung Kim: Severance Biomedical Science Institute
Hui-Yun Hwang: Yonsei University
Dong Jin Lee: Yonsei University
Haushabhau Pagire: Gwangju Institute of Science and Technology
Ho Jeong Kwon: Yonsei University
Jin Hee Ahn: Gwangju Institute of Science and Technology
Myung-Shik Lee: Severance Biomedical Science Institute

Nature Communications, 2018, vol. 9, issue 1, 1-14

Abstract: Abstract Autophagy is a critical regulator of cellular homeostasis, dysregulation of which is associated with diverse diseases. Here we show therapeutic effects of a novel autophagy enhancer identified by high-throughput screening of a chemical library against metabolic syndrome. An autophagy enhancer increases LC3-I to LC3-II conversion without mTOR inhibition. MSL, an autophagy enhancer, activates calcineurin, and induces dephosphorylation/nuclear translocation of transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy gene expression. MSL accelerates intracellular lipid clearance, which is reversed by lalistat 2 or Tfeb knockout. Its administration improves the metabolic profile of ob/ob mice and ameliorates inflammasome activation. A chemically modified MSL with increased microsomal stability improves the glucose profile not only of ob/ob mice but also of mice with diet-induced obesity. Our data indicate that our novel autophagy enhancer could be a new drug candidate for diabetes or metabolic syndrome with lipid overload.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-03939-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03939-w

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-03939-w

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03939-w